Drug
Navocaftor clinical trials
Also written ABBV-3067.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses navocaftor is read from its arms, and is right about nine times in ten.
Testing it · 6
- Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic FibrosisTerminatedPhase 2AbbVieNCT04853368Written as Navocaftor
- A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222CompletedPhase 2AbbVieNCT03969888Written as ABBV-3067
- A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 in Healthy Adults for the Treatment of Cystic FibrosisCompletedPhase 1AbbVieNCT05530278Written as Navocaftor
- A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and NavocaftorCompletedPhase 1AbbVieNCT05538585Written as Navocaftor
- Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis.CompletedPhase 1Galapagos NVNCT03589313Written as GLPG3067 single dose
- A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects.CompletedPhase 1Galapagos NVNCT03128606Written as GLPG3067 single dose
Codes
What other systems call navocaftor · ClinicalTrials.gg INT018296
- UNII (FDA) W2F2XU189ONAVOCAFTOROne source FDA
- NCI Thesaurus C174930NavocaftorOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | W2F2XU189O | NAVOCAFTOR | One source FDA |
| NCI Thesaurus | C174930 | Navocaftor | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.